JillM.HagenkordMD

Pathology • Omaha, NE

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Are you Dr. Hagenkord?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
601 N 30th St
Omaha, NE 68131
Phone+1 402-449-4630

Summary

Dr. Jill Hagenkord, MD is a board certified pathologist in Omaha, Nebraska. She is currently licensed to practice medicine in Nebraska, Utah, and California.

Education & Training

UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2007 - 2008
University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2002 - 2006
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1999 - 2002
Stanford University School of MedicineClass of 1999

Certifications & Licensure

CA State Medical License 2012 - 2025
UT State Medical License 2014 - 2022
NE State Medical License 2008 - 2014
IA State Medical License 2002 - 2012
PA State Medical License 2005 - 2008
American Board of Pathology Pathology - Clinical
American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

3 citations
Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Robert G Best, George Khushf, Sara Schonfeld Rabin-Havt, Ellen Wright Clayton, Theresa A Grebe
Genetics in Medicine. 2022-03-01
16 citations
Design and Reporting Considerations for Genetic Screening Tests
Jill M. Hagenkord, Birgit Funke, Emily Qian, Madhuri Hegde, Kevin B. Jacobs
The Journal of Molecular Diagnostics. 2020-05-01
18 citations
Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing.
James T. Lu, Matthew J. Ferber, Jill M. Hagenkord, Elissa Levin, Sarah T. South
The Journal of Molecular Diagnostics. 2019-01-01

Press Mentions

MDisrupt Launches a Medical Diligence Service to Bring Scientific Rigor to Silicon ValleyAugust 25th, 2019
MDisrupt Launches the World’s First Medical Diligence CompanyAugust 21st, 2019
Morning Headlines 8/13/19August 12th, 2019
Join now to see all